WO2025120580 - COMPOSITIONS AND METHODS FOR INITIATING A MUCOSAL IMMUNE RESPONSE
National phase entry is expected:
Publication Number
WO/2025/120580
Publication Date
12.06.2025
International Application No.
PCT/IB2024/062289
International Filing Date
06.12.2024
Title **
[English]
COMPOSITIONS AND METHODS FOR INITIATING A MUCOSAL IMMUNE RESPONSE
[French]
COMPOSITIONS ET MÉTHODES POUR INDUIRE UNE RÉPONSE IMMUNITAIRE MUCOSALE
Applicants **
IX BIOPHARMA LTD
Inventors
LIM, Chin Beng Stephen
LEE, Yip Hang Eddy
COOK, Iain Bruce
Priority Data
2023903976
08.12.2023
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 7289 | |
| EPO | Filing, Examination, Granting | 200979 | |
| Japan | Filing, Examination, Granting | 5280 | |
| South Korea | Filing, Examination, Granting | 12603 | |
| USA | Filing, Examination, Granting | 42240 |
Total:
268,391
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to compositions comprising a biological active material. The present invention also relates to pharmaceutical compositions, dosage forms and methods for initiating a mucosal immune response.[French]
La présente invention concerne des compositions comprenant une matière active biologique. La présente invention concerne également des compositions pharmaceutiques, des formes posologiques et des méthodes pour induire une réponse immunitaire mucosale.